We support reforms which will allow all Canadians to access the medicines they need when needed, equitably and consistently, as outlined in our core positions and principles, and in formal submissions.
BMC Submission to Pharmacare Advisory Council:
Statement Regarding National Pharmacare Interim Report Announcement
Joint Discussion Paper:
Better Pharmacare For Patients: Evaluating Policy Options (Français)
We a support a national regulatory framework which protects Canadian patients, including addressing supply issues like drug shortages which put patients at risk.
We seek pharmaceutical assessment which incorporates patient-driven evidence and perspectives and leads to improved patient care.